Quercitrin, the Main Compound in Wikstroemia indica, Mitigates Skin Lesions in a Mouse Model of 2,4-Dinitrochlorobenzene-Induced Contact Hypersensitivity
- 문서 유형
- 연구출판물 · 학술지 논문
- 등재
- SCIEScopus
- 저널 순위
- JCR Q3Scopus Q2
- 피인용
- Web of Science 16Scopus 18
- FWCI (Scopus)
- 0
- JCR IF
- JCR 2019 1.813
- ISSN
- 1741-427X
저자
- 제갈종환제1저자College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
- Park, No-JuneNatural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451 Republic of Korea kist.re.kr
- 이소연College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
- 조범근College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
- Bong, Sim-KyuNatural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451 Republic of Korea kist.re.kr
- Kim, Su-Nam교신저자Natural Products Research Institute, Korea Institute of Science and Technology, Gangneung 25451 Republic of Korea kist.re.kr
- 양민혜교신저자College of Pharmacy, Pusan National University, Busan 46241 Republic of Korea pusan.ac.kr
초록
Hapten-induced contact hypersensitivity (CHS) is widely utilized to induce immune activation in animal models of allergic contact dermatitis. Our previous findings suggested that the 95% EtOH extract ofWikstroemia indica(L.) C. A. Mey. has antiallergic and anti-inflammatory effects in DNCB-treated CHS SKH-1 hairless mice. The aim of this study was to evaluate the protective effects of compounds isolated from the EtOAc fraction ofW. indicain RBL-2H3 cells and 2,4-dinitrochlorobenzene- (DNCB-) induced CHS mice. Of eight compounds inW. indica, that is, umbelliferone, daphnoretin, wikstrocoumarin, (+)-syringaresinol, tricin, (+)-lariciresinol,erythro-guaiacylglycerol-beta-coniferyl ether, and quercitrin, quercitrin exhibited the most antiallergic activity against antigen-induced beta-hexosaminidase release and IL-4 mRNA expression, which are markers of degranulation in RBL-2H3 cells. After a 7-sensitizing period, 14 days of DNCB treatment with or without topical pimecrolimus (1%) or quercitrin (0.5%) treatment, quercitrin was found to suppress DNCB-induced increases in serum IL-4 and IgE concentrations and transepidermal water loss. These results indicate that quercitrin has therapeutic potential for treatment of allergies and allergy-related contact dermatitis.
키워드
ATOPIC-DERMATITISMOLECULAR-MECHANISMSBARRIER DYSFUNCTIONDIETARY FLAVONOIDSIMMUNE-RESPONSESQUERCETIN
식별자
- Scopus EID
- 2-s2.0-85089144968
- WoS UID
- 000553395700005



로그인
연구물 목록으로